BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 24350989)

  • 1. Cardiac biomarkers in hyperthyroid cats.
    Sangster JK; Panciera DL; Abbott JA; Zimmerman KC; Lantis AC
    J Vet Intern Med; 2014; 28(2):465-72. PubMed ID: 24350989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma cardiac troponin I concentration and cardiac death in cats with hypertrophic cardiomyopathy.
    Borgeat K; Sherwood K; Payne JR; Luis Fuentes V; Connolly DJ
    J Vet Intern Med; 2014; 28(6):1731-7. PubMed ID: 25319115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac troponin I and T as prognostic markers in cats with hypertrophic cardiomyopathy.
    Langhorn R; Tarnow I; Willesen JL; Kjelgaard-Hansen M; Skovgaard IM; Koch J
    J Vet Intern Med; 2014; 28(5):1485-91. PubMed ID: 25056593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superiority of high sensitivity cardiac troponin I over NT-proBNP and adiponectin for 7-year mortality in stable patients receiving haemodialysis.
    Iwamura N; Kidoguchi S; Asahi N; Takeda I; Matsuta K; Miyagi K; Iwano M; Miyazaki R; Kimura H
    Sci Rep; 2024 May; 14(1):11488. PubMed ID: 38769120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Serum Symmetric Dimethylarginine Concentration as a Marker for Masked Chronic Kidney Disease in Cats With Hyperthyroidism.
    Peterson ME; Varela FV; Rishniw M; Polzin DJ
    J Vet Intern Med; 2018 Jan; 32(1):295-304. PubMed ID: 29377360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of point-of-care thoracic ultrasound and NT-proBNP for the diagnosis of congestive heart failure in cats with respiratory distress.
    Ward JL; Lisciandro GR; Ware WA; Viall AK; Aona BD; Kurtz KA; Reina-Doreste Y; DeFrancesco TC
    J Vet Intern Med; 2018 Sep; 32(5):1530-1540. PubMed ID: 30216579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac biomarker responses following high-intensity interval and continuous exercise: the influence of ACE-I/D gene polymorphism and training status in men.
    Falahati A; Arazi H
    Physiol Genomics; 2024 Jun; 56(6):436-444. PubMed ID: 38586874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological features and comorbidities of cats with mild, moderate or severe hyperthyroidism: a radioiodine referral population.
    Watson N; Murray JK; Fonfara S; Hibbert A
    J Feline Med Surg; 2018 Dec; 20(12):1130-1137. PubMed ID: 29432704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation parameters in hyperthyroid cats before and after radioiodine treatment compared with healthy controls.
    Cui Y; Heuser K; Bauer N; Neiger R
    J Feline Med Surg; 2019 Dec; 21(12):1134-1140. PubMed ID: 30571457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between total thyroxine, thyroid palpation and a clinical index in hyperthyroid and healthy cats and cats with other diseases.
    Wehner A; Koehler I; Ramspott S; Hartmann K
    J Feline Med Surg; 2019 Aug; 21(8):741-749. PubMed ID: 30328752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac troponin I in cats with compromised renal function.
    Langhorn R; Jessen LR; Kloster AS; Jensen AP; Koch J
    J Feline Med Surg; 2019 Oct; 21(10):985-991. PubMed ID: 31551016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma growth differentiation factors 8 and 11 levels in cats with congestive heart failure secondary to hypertrophic cardiomyopathy.
    Yang VK; Rush JE; Bhasin S; Wagers AJ; Lee RT
    J Vet Cardiol; 2019 Oct; 25():41-51. PubMed ID: 31568985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed-release rapamycin halts progression of left ventricular hypertrophy in subclinical feline hypertrophic cardiomyopathy: results of the RAPACAT trial.
    Kaplan JL; Rivas VN; Walker AL; Grubb L; Farrell A; Fitzgerald S; Kennedy S; Jauregui CE; Crofton AE; McLaughlin C; Van Zile R; DeFrancesco TC; Meurs KM; Stern JA
    J Am Vet Med Assoc; 2023 Nov; 261(11):1628-1637. PubMed ID: 37495229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum metabolome analysis in hyperthyroid cats before and after radioactive iodine therapy.
    Bechtold MA; Lin Y; Miller ML; Prieto JM; Frederick CE; Bennett LL; Peterson ME; Simpson KW; Loftus JP
    PLoS One; 2024; 19(6):e0305271. PubMed ID: 38857299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of, and factors associated with, positive urine cultures in hyperthyroid cats presenting for radioiodine therapy.
    Keebaugh AE; DeMonaco SM; Grant DC; Panciera DL
    J Feline Med Surg; 2021 Feb; 23(2):74-78. PubMed ID: 32478636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet function in cats with hyperthyroidism.
    Hiebert EC; Panciera DL; Boes KM; Bartl L
    J Feline Med Surg; 2020 Dec; 22(12):1214-1218. PubMed ID: 32436801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between feline hyperthyroidism and thoracic radiographic evaluation of cardiomegaly and pulmonary hyperinflation.
    Young V; Rao S; Shropshire SB; Marolf AJ
    J Feline Med Surg; 2022 Oct; 24(10):e394-e400. PubMed ID: 36043487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor type 1 concentrations in hyperthyroid cats before and after treatment with thiamazole.
    Rochel D; Burger M; Nguyen P; Jaillardon L
    J Feline Med Surg; 2018 Feb; 20(2):179-183. PubMed ID: 29172902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure in hyperthyroid cats before and after radioiodine treatment.
    Stammeleer L; Xifra P; Serrano SI; Rishniw M; Daminet S; Peterson ME
    J Vet Intern Med; 2024; 38(3):1359-1369. PubMed ID: 38440934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Echocardiographic, morphometric and biomarker changes in female cats followed from 6 to 24 months of life.
    van Hoek IM; Laxalde J; Connolly DJ; Rush JE; Freeman LM
    J Feline Med Surg; 2021 Apr; 23(4):278-286. PubMed ID: 32720562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.